Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist. 1987

M Williams, and J Francis, and G Ghai, and A Braunwalder, and S Psychoyos, and G A Stone, and W D Cash

CGS 15943A, a triazoloquinazoline, is a potent and selective adenosine receptor antagonist as assessed by its effects on radioligand binding and adenosine-stimulated adenylate cyclase activity in guinea pig synaptoneurosomes. At the adenosine A-1 receptor labeled with [3H]cyclohexyladenosine, CGS 15943A had an IC50 value of 20 nM. At the striatal A-2 receptor labeled with [3H]5'-N-ethylcarboxamidoadenosine in the presence of a low concentration of cyclopentyladenosine to block A-1 receptors labeled by this nonselective adenosine agonist, CGS 15943A had an IC50 value of 3 nM, indicating that the compound had some degree of selectivity for the A-2 receptor. Analysis of the effect of the compound on the saturation isotherms for each of the receptors indicated that it was a competitive antagonist at the brain A-1 receptor but that it was noncompetitive at the striatal A-2 receptor. CGS 15943A was a potent adenosine antagonist in the adenosine-stimulated adenylate cyclase system in guinea pig synaptoneurosomes, where the compound was found to have an IC50 value of 30 to 70 nM against the increase in cyclic AMP evoked by 5 microM adenosine. CGS 15943A had no effect on the binding of [3H]nitrobenzylthioinosine, a ligand thought to bind to adenosine uptake sites, and, at a concentration of 10 microM, had no effect on beef heart type III phosphodiesterase activity.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D011983 Receptors, Purinergic Cell surface proteins that bind PURINES with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized classes of purinergic receptors in mammals are the P1 receptors, which prefer ADENOSINE, and the P2 receptors, which prefer ATP or ADP. Methyladenine Receptors,Purine Receptors,Purinergic Receptor,Purinergic Receptors,Purinoceptors,Purine Receptor,Purinoceptor,Receptors, Methyladenine,Receptors, Purine,Receptor, Purine,Receptor, Purinergic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

M Williams, and J Francis, and G Ghai, and A Braunwalder, and S Psychoyos, and G A Stone, and W D Cash
July 1998, Journal of medicinal chemistry,
M Williams, and J Francis, and G Ghai, and A Braunwalder, and S Psychoyos, and G A Stone, and W D Cash
December 1994, Methods and findings in experimental and clinical pharmacology,
M Williams, and J Francis, and G Ghai, and A Braunwalder, and S Psychoyos, and G A Stone, and W D Cash
October 1993, The Journal of pharmacology and experimental therapeutics,
M Williams, and J Francis, and G Ghai, and A Braunwalder, and S Psychoyos, and G A Stone, and W D Cash
January 1991, Molecular pharmacology,
M Williams, and J Francis, and G Ghai, and A Braunwalder, and S Psychoyos, and G A Stone, and W D Cash
May 1996, The Journal of pharmacology and experimental therapeutics,
M Williams, and J Francis, and G Ghai, and A Braunwalder, and S Psychoyos, and G A Stone, and W D Cash
June 1995, European journal of pharmacology,
M Williams, and J Francis, and G Ghai, and A Braunwalder, and S Psychoyos, and G A Stone, and W D Cash
July 1999, European journal of pharmacology,
M Williams, and J Francis, and G Ghai, and A Braunwalder, and S Psychoyos, and G A Stone, and W D Cash
January 1994, Life sciences,
M Williams, and J Francis, and G Ghai, and A Braunwalder, and S Psychoyos, and G A Stone, and W D Cash
January 1991, Life sciences,
M Williams, and J Francis, and G Ghai, and A Braunwalder, and S Psychoyos, and G A Stone, and W D Cash
January 1999, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!